Stephen R. Warzala - 05 Mar 2026 Form 4 Insider Report for ALLIENT INC (ALNT)

Role
VP and Group President
Signature
/s/ Michael C. Donlon, Attorney-in-Fact for Stephen R. Warzala
Issuer symbol
ALNT
Transactions as of
05 Mar 2026
Net transactions value
$0
Form type
4
Filing time
09 Mar 2026, 20:00:55 UTC
Previous filing
02 Jan 2026
Next filing
03 Apr 2026
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Stephen R. Warzala filed Form 4 for ALLIENT INC (ALNT) on 09 Mar 2026."

Quick Takeaways

  • This page summarizes Stephen R. Warzala's Form 4 filing for ALLIENT INC (ALNT).
  • 3 reported transactions and 0 derivative rows are listed below.
  • Filing timestamp: 09 Mar 2026, 20:00.

What Changed

  • Previous filing in this sequence was filed on 02 Jan 2026.
  • Current net transaction value: $0.

Why This Matters

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Official SEC Source

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Warzala Stephen VP and Group President C/O ALLIENT INC., 495 COMMERCE DRIVE, AMHERST /s/ Michael C. Donlon, Attorney-in-Fact for Stephen R. Warzala 09 Mar 2026 0002048616

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALNT Common Stock Award +1,664 +5.1% $62.07* 34,494 05 Mar 2026 Direct F1
transaction ALNT Common Stock Award +1,189 +3.4% $62.07* 35,683 05 Mar 2026 Direct F2
transaction ALNT Common Stock Award +345 +0.97% $62.07* 36,028 05 Mar 2026 Direct F3
holding ALNT Common Stock 110,000 05 Mar 2026 By Trust (Reporting Person as co-trustee and beneficiary)
holding ALNT Common Stock 2,801 05 Mar 2026 By Trust (Reporting Person as trustee)
holding ALNT Common Stock 4,200 05 Mar 2026 By ESOP Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of time-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares vest one-third each on April 1, 2027, 2028 and 2029.
F2 Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. All or a portion of these restricted shares will vest over a three-year period upon the satisfaction of certain performance goals established by the Compensation Committee for the year ending December 31, 2026.
F3 Grant of performance-based restricted shares pursuant to the Company's 2017 Omnibus Incentive Plan. These restricted shares were earned upon the satisfaction of certain performance goals established by the Compensation Committee for the year ended December 31, 2025 and vest one-third each on April 1, 2026, 2027 and 2028.

Sponsored